Neuroendocrine Effects of Androgens in Adult Polycystic Ovary Syndrome and Female Puberty
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In addition to hyperandrogenism and ovulatory dysfunction, polycystic ovary syndrome (PCOS) is characterized by neuroendocrine abnormalities including a persistently rapid gonadotropin-releasing hormone (GnRH) pulse frequency. Rapid GnRH pulsatility favors pituitary secretion of luteinizing hormone (LH) over that of follicle-stimulating hormone (FSH). Excess LH stimulates ovarian androgen production, whereas relative deficits in FSH impair follicular development. The rapid GnRH pulse frequency is a result of reduced progesterone-mediated feedback inhibition of the GnRH pulse generator secondary to infrequent luteal phase increases in progesterone, as well as reduced hypothalamic sensitivity to progesterone feedback. Progesterone sensitivity is restored by treatment with the androgen receptor blocker flutamide. As such, hyperandrogenemia appears to play an important pathophysiologic role in PCOS. Adolescent hyperandrogenemia is believed to be a precursor to adult PCOS. In addition to increased LH concentrations and pulse frequency, some girls with elevated androgen levels also demonstrate reduced hypothalamic sensitivity to progesterone feedback. We hypothesize that excess peripubertal androgens may reduce the sensitivity of the GnRH pulse generator to sex steroid inhibition in susceptible individuals, resulting in increased GnRH pulse frequency and subsequent abnormalities in gonadotropin secretion, ovarian androgen production, and ovulatory function. Over time, these abnormalities may progress to the clinical hyperandrogenism and chronic oligo-ovulation typical of adult PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FILICORI, M., SANTORO, N., MERRIAM, G. R., & CROWLEY, W. F. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-6-1136 · Cited by 489
Cited by
Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
Glueck, C. J., & Goldenberg, N. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.002 · Cited by 442
Sen, A., & Hammes, S. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0006 · Cited by 312
Sen, A., Prizant, H., Light, A., Biswas, A., Hayes, E., Lee, H.-J., Barad, D., Gleicher, N., & Hammes, S. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318978111 · Cited by 282
Gonadotropin regulation by pulsatile GnRH: Signaling and gene expression
Stamatiades, G. A., & Kaiser, U. B. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.10.015 · Cited by 272
GnRH pulse frequency-dependent differential regulation of LH and FSH gene expression
Thompson, I. R., & Kaiser, U. B. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.012 · Cited by 199
“This disorder affects 5-15 % of the female population within reproductive age, and is also linked to obesity, insulin resistance, as well as other metabolic and cardiovascular abnormalities (Blank et al., 2007; Dunaif, 1997; Hoffman and Ehrmann, 2008).”
BackgroundNeuroendocrine dysfunction in polycystic ovary syndrome
Burt Solorzano, C. M., Beller, J. P., Abshire, M. Y., Collins, J. S., McCartney, C. R., & Marshall, J. C. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.007 · Cited by 173
Self-citationPolycystic Ovary Syndrome in Adolescence
Blank, S. K., Helm, K. D., McCartney, C. R., & Marshall, J. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.005 · Cited by 97
Self-citationGenetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology
Dadachanji, R., Shaikh, N., & Mukherjee, S. (2018) · Genetics Research International · doi:10.1155/2018/7624932 · Cited by 90
“An intronic variant rs2414096 was shown to be significantly associated with increased risk of PCOS development and with increased estradiol to testosterone ratio (E2/T), FSH levels, and age of menarche in Han Chinese women [90].”
InfluentialNaltrexone treatment in clomiphene resistant women with polycystic ovary syndrome
Ahmed, M. I., Duleba, A. J., El Shahat, O., Ibrahim, M. E., & Salem, A. (2008) · Human Reproduction · doi:10.1093/humrep/den273 · Cited by 58
“Salient features of PCOS include hyperandrogenism and chronic anovulation, often in association with insulin resistance, as well as alterations in GnRH pulse frequency and gonadotrophin release (Barnes and Rosenfield, 1989; Morales et al., 1996; Blank et al., 2007).”
BackgroundNon-classic congenital adrenal hyperplasia
Witchel, S. F. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.010 · Cited by 52
Infertility and Reproductive Function in Patients with Congenital Adrenal Hyperplasia
Lekarev, O., Lin-Su, K., & Vogiatzi, M. G. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.07.009 · Cited by 38
Wang, X., Wang, H., Liu, W., Zhang, Z., Zhang, Y., Zhang, W., Chen, Z., Xia, G., & Wang, C. (2018) · Clinical Science · doi:10.1042/cs20171394 · Cited by 30
El Maghraby, H. A., Nafee, T., Guiziry, D., & Elnashar, A. (2015) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2014.10.003 · Cited by 19
Metadata
- Authors
- Blank, S., McCartney, C., Helm, K., & Marshall, J.
- Venue
- Seminars in Reproductive Medicine
- Publisher
- Georg Thieme Verlag KG
- Published
- 2007-09
- Volume
- 25
- Issue
- 5
- Pages
- 352-359
- ISSN
- 1526-4564 (ISSN-L)
- 1526-8004
- OpenAlex
- W2079472989
- Cited by
- 116
- References
- 1
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.